ferric citrate has been researched along with Cholera Infantum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiba, T; Chertow, GM; Fukagawa, M; Hirakata, H; Kumagai, Y; Nakayama, M; Sawada, K; Yokoyama, K | 1 |
| Iida, A; Maeda, K; Matsumoto, Y; Matsuo, A; Miyazaki, A; Nishino, N; Orui, S | 1 |
1 review(s) available for ferric citrate and Cholera Infantum
| Article | Year |
|---|---|
[Pharmacological profile and clinical findings of a new phosphate binder, ferric citrate hydrate (Riona® Tablets)].
Topics: Animals; Chelating Agents; Clinical Trials as Topic; Ferric Compounds; Ferritins; Gastrointestinal Diseases; Humans; Hyperphosphatemia; Peritoneal Dialysis; Renal Dialysis; Renal Insufficiency, Chronic; Tablets | 2014 |
1 trial(s) available for ferric citrate and Cholera Infantum
| Article | Year |
|---|---|
Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis.
Topics: Aged; Calcium; Dose-Response Relationship, Drug; Endpoint Determination; Female; Ferric Compounds; Ferritins; Gastrointestinal Diseases; Hematinics; Humans; Hyperphosphatemia; Iron; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis | 2014 |